Fontana, R J <br/><br/>
The caffeine breath test does not identify patients susceptible to tacrine hepatotoxicity.  [electronic resource] 

 -  Hepatology (Baltimore, Md.)  Jun 1996 
 - 1429-35 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0270-9139 
<br/><br/><label>Standard No.: </label>10.1002/hep.510230619  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Alanine Transaminase--blood<br/>Alzheimer Disease--drug therapy<br/>Breath Tests<br/>Caffeine--pharmacokinetics<br/>Cholinesterase Inhibitors--adverse effects<br/>Cytochrome P-450 CYP1A2<br/>Cytochrome P-450 Enzyme System--metabolism<br/>Female<br/>Humans<br/>Liver--drug effects<br/>Male<br/>Middle Aged<br/>Oxidoreductases--metabolism<br/>Tacrine--adverse effects